<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0012115'>Hepatitis</z:hpo> C, a worldwide <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, is an important health problem in Brazil </plain></SENT>
<SENT sid="1" pm="."><plain>The virus causes <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, provoking <z:mp ids='MP_0002459'>B lymphocyte dysfunction</z:mp>, as represented by <z:hpo ids='HP_0100778'>cryoglobulinemia</z:hpo>, non-organ-specific autoantibody production, and non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this research was to screen for the presence of antiphospholipid autoantibodies in 109 Brazilian <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus carriers without clinical history of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Forty healthy individuals were used as the control group </plain></SENT>
<SENT sid="4" pm="."><plain>IgA, IgG, and IgM antibodies against <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> and ss2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I were measured with an enzyme-linked immunosorbent assay, using a cut-off point of either 20 UPL or 20 SBU </plain></SENT>
<SENT sid="5" pm="."><plain>While 24 (22.0%) <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C carriers had moderate titers of IgM anticardiolipin antibodies (median, 22.5 MPL; 95%CI: 21.5-25.4 MPL), only three carriers (&lt;3%) had IgG anticardiolipin antibodies (median, 23 GPL; 95%CI: 20.5-25.5 GPL) </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, IgA anticardiolipin antibodies were not detected in these individuals </plain></SENT>
<SENT sid="7" pm="."><plain>Male gender and IgM anticardiolipin seropositivity were associated in the <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C group (P = 0.0004) </plain></SENT>
<SENT sid="8" pm="."><plain>IgA anti-ss2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi>-I antibodies were detected in 29 of 109 (27.0%) <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C carriers (median, 41 SAU; 95%CI: 52.7-103.9 SAU) </plain></SENT>
<SENT sid="9" pm="."><plain>Twenty patients (18.0%) had IgM anti-ss2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies (median, 27.6 SMU; 95%CI: 23.3-70.3 SMU), while two patients had IgG antibodies against this protein (titers, 33 and 78 SGU) </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> were detected in only one healthy individual, who was seropositive for IgM anticardiolipin </plain></SENT>
<SENT sid="11" pm="."><plain>We concluded that Brazilian individuals chronically infected with <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C virus present a significant production of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo>, mainly IgA anti-ss2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies, which are not associated with clinical manifestations of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>